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Summary In a prospective study of about 22,000 men attending a well person screening centre, serum
samples were collected and stored. The concentration of retinol was measured in the stored serum samples
from 227 men subsequently notified as having cancer and from 454 unaffected controls, matched for age,
smoking history and duration of storage of the serum samples. The mean serum retinol concentration of the
cancer subjects who developed cancer before the elapse of one year since the time blood was collected was
significantly lower than the mean concentration of their matched controls (641 and 722pgl-1 respectively,
P<0.001). For subjects whose cancer developed one to two years after blood had been collected, the
difference was less (650 and 701 pgl- respectively, P<0.01). For subjects whose cancer developed three or
more years after blood was collected, the mean retinol level was higher than in their controls, although not
statistically significantly so (694 and 663 ig1- I respectively). These findings suggest that the inverse
association between serum retinol and risk of cancer that was previously observed was due to low serum
retinol being a metabolic consequence of cancer rather than a precursor of cancer.
In an earlier paper (Wald et al., 1980a) we reported
the preliminary results from a prospective study of
about 16,000 men who attended a well person
screening centre. At their visit a serum sample was
collected and stored. Serum retinol levels were later
measured in the stored samples from the 86 men
who were subsequently notified as having developed
cancer and from 172 controls who were free from
cancer. Low retinol levels were associated with an
increased risk of cancer.
The association we observed could have arisen
because low retinol levels were a metabolic
consequence of the cancer or because cancer was
more likely to arise in subjects who had low serum
retinol levels. We concluded that the results
supported the latter explanation because the mean
serum retinol level in those for whom there was a
suspicion of cancer when the serum was collected
was not lower than in those for whom there was no
evidence of cancer at the time.
Since our publication, a number of other
prospective epidemiological studies have been
reported on serum retinol and cancer; one yielded a
similar result (Kark et al., 1981), another did so
only in smokers (Salonen et al., 1985), but the
others showed either no significant association or
one of smaller magnitude (Wald et al., 1984; Willett
et al., 1984a,b; Menkes & Comstock, 1984; Peleg et
al., 1984; Stahelin et al., 1984; Nomura et al.,
1985; Friedman et al., 1986).
To investigate the matter further we continued to
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make observations on the same cohort of men as
well as on an additional 6,000 men and now report
an examination of new data on serum retinol and
cancer. We pay special attention to the results in
relation to the interval between the collection of
serum and the diagnosis of the cancer and compare
our present results with our earlier ones.
Methods
The design of our prospective study has been
described (Wald et al., 1980). About 22,000 men
aged 35-64 attended the BUPA Medical Centre in
London for a-comprehensive medical examination
between March 1975 and March 1982. Blood was
collected at this examination and stored at -40°C.
The National Health Service records for these men
were flagged and through the assistance of the
Offlce of Population Censuses and Surveys (OPCS)
notification was received in the event of cancer or
death. By April 1985, 227 men were identified as
having developed cancer (subjects) excluding the 86
men who were the subjects of our preliminary
study. As before two controls were selected for each
of the subjects, matched on age (within 5 years),
duration of storage of the serum sample (within 3
months), calendar quarter of attendance at the
Medical Centre, smoking status (current smoker,
ex-smoker or lifelong non-smoker) and, for current
smokers, smoking habits - type of product smoked
(cigarette, cigar or pipe), amount smoked (within 5
cigarettes/day, 2 cigars/day or an ounce of
tobacco/week) and age started smoking (within 5
years).
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The retinol estimations were performed in the
same laboratory and by the same method as before
(high pressure liquid chromatography) (Vuilleumier
et al., 1983). Samples were tested in three separate
series with about two years between each; sera from
subjects and their matched controls were always
assayed in the same analytical batch. Mean retinol
concentrations were standardised using the indirect
method, to take account of any changes in assay
performance between each series.
Results
The mean retinol concentration for all subjects was
similar to that for all controls, ignoring the interval
between blood collection and diagnosis of cancer
(670 and 688 1ugl-1 respectively). Table I shows the
mean serum retinol concentration of subjects and
matched controls according to the site of the cancer
and the interval between blood collection and
diagnosis of cancer. Particular cancer sites were
analysed separately if, for each interval between
blood collection and diagnosis, 5 or more men had
developed cancer at that site. Other sites were
grouped together. There was a statistically
significant difference for those subjects whose
cancer developed before the elapse of one year since
the blood was collected compared with their
matched controls (641 and 722jugl-1 respectively).
For subjects whose cancer developed 1-2 years after
blood had been collected the difference was less
(650 and 701 ig 1-1 respectively) but still
statistically significant. For subjects whose cancers
developed three or more years after blood was
collected, the difference was not statistically
significant and the retinol level in the subjects was
actually higher than that in their controls (694 and
663 ug 1- 1 respectively). For these subjects, there
was no suggestion of a difference in serum retinol
between subjects and controls for cancers at any of
the specified sites. Also categorisation of the data
into finer time periods (between cancer developing
and blood sampling) did not alter the conclusions.
Table II shows the serum retinol levels for
subjects and controls from our preliminary study
according to the time between collection of the
blood sample and the diagnosis of cancer. (In the
preliminary study, retinol levels were expressed in
iudl-1. Here they have been converted into ,ugl-1;
I iudl- I is equivalent to 3 ,ug 1- 1). The preliminary
and the second study yield consistent results (Tables
II and I respectively). The inverse association
between serum retinol and cancer observed in the
preliminary study is evident in the second study,
but only for subjects in whom the diagnosis of
cancer occurred less than three years after blood
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was collected. A similar conclusion can be drawn
from Table III which shows the number of subjects
and controls according to quintile of retinol
concentration in both the preliminary and the
second study. There is a statistically significant
inverse trend among the subjects in whom a
diagnosis was made before the elapse of three years
since blood was taken, but this was not the case for
those diagnosed later.
Discussion
We have confirmed the inverse association between
serum retinol and cancer that we reported before
(Wald et al., 1980a) but, with the longer follow-up
possible in this second study, found that the
association was restricted to men who were notified
as having cancer less than three years after blood
was collected. This suggests that the low serum
retinol levels were a metabolic consequence of the
cancer rather than a precursor, even though the
cancer may not have been symptomatic or clinically
apparent when blood was collected.
Although in our preliminary study serum retinol
levels were not materially related to the matching
criteria, in this one there was a small but
statistically significant decrease in serum retinol
with age (736, 727, 676, 701, 678, 662pgI-1 for
controls aged 35-39, 40-44, 45-49, 50-54, 55-59,
60-64 respectively). There was also a suggestion of
some decrease in retinol levels with storage beyond
about 5 years (688, 732, 713, 655, 658ugl-1 for
samples from controls stored for 0-, 2-, 4-, 6-, 8+
years).
In the two other studies showing an inverse
association between serum retinol and cancer, one
(Salonen et al., 1985) had a short follow-up, similar
to our preliminary study and this may have
explained the finding. The other study (Kark et al.,
1981) had a longer follow-up, but, unlike our own,
the serum samples from cancer subjects had been
repeatedly frozen and thawed. This was not the
case with samples from the controls and the
difference may have accounted for the lower retinol
levels observed in subjects compared with controls.
Our results on serum retinol and cancer are
similar to those of Rose and Shipley (1980), on
serum cholesterol and cancer. In their study, low
serum cholesterol levels were found in persons who
developed cancer within two years of blood
collection but not in those who developed cancer
later. They also concluded that this was a metabolic
consequence of the cancer. Serum cholesterol and
serum retinol are known to be associated (Kark et
al., 1982; Marenah et al., 1983) and this was
evident in our study, (r=0.12, P<0.01 among the
controls and r=0.24, P<0.001 among the subjects).
The association suggests that they are both
determined by a third factor which is itself affected
by cancer, or less plausibly, that one level
determines the other directly.
The results now available make it unlikely that
retinol in the concentrations present in the sera of
residents of developed countries had any substantial
effect on the risk of developing cancer. It follows
that either the lowest levels typically found in
developed countries are above that which produces
an observable effect or that the preventive action
suggested by animal and in vitro experiments (Sporn
et al., 1984) is not apparent at concentrations
naturally found in man.
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